← Back
Data updated: Mar 10, 2026
FEINSTEIN
Neurology
FEINSTEIN is a pharmaceutical company focused on Neurology. Key products include FLUORODOPA F18.
2005
Since
3
Drugs
-
Trials
2
Approved (2yr)
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (0)
Company Info
- First Approval
- 2005-08-19
- Latest
- 2023-11-09
- Applications
- 3